- Home
- RXST vs ACB Comparison
RXST vs ACB Comparison
Compare RXST & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXST
- ACB
- Stock Information
- Founded
- RXST 1997
- ACB 2013
- Country
- RXST United States
- ACB Canada
- Employees
- RXST N/A
- ACB N/A
- Industry
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ACB Pharmaceuticals and Biotechnology
- Sector
- RXST Health Care
- ACB Health Care
- Exchange
- RXST Nasdaq
- ACB Nasdaq
- Market Cap
- RXST 307.3M
- ACB 264.2M
- IPO Year
- RXST 2021
- ACB N/A
- Fundamental
- Price
- RXST $9.75
- ACB $4.34
- Analyst Decision
- RXST Hold
- ACB
- Analyst Count
- RXST 11
- ACB 0
- Target Price
- RXST $11.20
- ACB N/A
- AVG Volume (30 Days)
- RXST 698.7K
- ACB 1.1M
- Earning Date
- RXST 11-05-2025
- ACB 11-05-2025
- Dividend Yield
- RXST N/A
- ACB N/A
- EPS Growth
- RXST N/A
- ACB N/A
- EPS
- RXST N/A
- ACB N/A
- Revenue
- RXST $142,085,000.00
- ACB $263,570,704.00
- Revenue This Year
- RXST N/A
- ACB $9.42
- Revenue Next Year
- RXST $6.71
- ACB $5.72
- P/E Ratio
- RXST N/A
- ACB N/A
- Revenue Growth
- RXST 10.75
- ACB 23.89
- 52 Week Low
- RXST $6.32
- ACB $3.42
- 52 Week High
- RXST $47.89
- ACB $6.91
- Technical
- Relative Strength Index (RSI)
- RXST 58.46
- ACB 34.36
- Support Level
- RXST $8.24
- ACB $4.33
- Resistance Level
- RXST $10.77
- ACB $4.76
- Average True Range (ATR)
- RXST 0.74
- ACB 0.22
- MACD
- RXST 0.13
- ACB -0.04
- Stochastic Oscillator
- RXST 61.15
- ACB 6.98
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
About ACB Aurora Cannabis Inc.
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.